FactSet Research Systems Inc. (FDS)
FactSet Research Systems: Reiterate Buy As Bull Case Gets Clearer
I reiterate my strong buy rating for FactSet Research Systems (FDS) due to strong EPS growth, pipeline bookings, and AI-driven product traction. FDS reported 2Q25 revenue of $570.7 million, with a healthy EBIT margin of 37.3%, and increased FY25 revenue guidance to $2.305-$2.325 billion. FDS's AI strategy, particularly Pitch Creator, shows promising adoption, with >2,000 active trials and >50 pipeline opportunities, enhancing productivity for investment bankers.
FactSet: Not Yet A Buy; At $400 Per Share It Might Be
FactSet's business model is robust, driven by recurring revenues and high client retention, making it a reliable investment even during market turmoil. Q2 FY2025 results showed modest growth in subscriptions, revenues, and EPS, but market reaction was negative, causing a 2% drop in stock price. FactSet's dividend is sustainable and growing, but its current yield is low, making it less attractive for dividend-focused investors.
FactSet Research Systems Inc. (FDS) Q2 2025 Earnings Call Transcript
FactSet Research Systems Inc. (NYSE:FDS ) Q2 2025 Earnings Conference Call March 20, 2025 9:00 AM ET Company Participants Yet He - Interim Head of IR Philip Snow - Chief Executive Officer Helen Shan - Chief Financial Officer Goran Skoko - Chief Revenue Officer Conference Call Participants Kelsey Zhu - Autonomous Shlomo Rosenbaum - Stifel Alex Kramm - UBS Faiza Alwy - Deutsche Bank Ashish Sabadra - RBC Brendan Popson - Barclays Owen Lau - Oppenheimer Andrew Nicholas - William Blair Craig Huber - Huber Research Partners George Tong - Goldman Sachs Toni Kaplan - Morgan Stanley Ryan Griffin - BMO Capital Markets Jason Haas - Wells Fargo Surinder Thind - Jefferies Operator Good day, and thank you for standing by. Welcome to the FactSet Second Quarter 2025 Earnings Conference Call.
FactSet (FDS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for FactSet (FDS) give a sense of how the business performed in the quarter ended February 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
FactSet Research (FDS) Tops Q2 Earnings Estimates
FactSet Research (FDS) came out with quarterly earnings of $4.28 per share, beating the Zacks Consensus Estimate of $4.19 per share. This compares to earnings of $4.22 per share a year ago.
Unlocking Q2 Potential of FactSet (FDS): Exploring Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for FactSet (FDS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended February 2025.
Analysts Estimate FactSet Research (FDS) to Report a Decline in Earnings: What to Look Out for
FactSet (FDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
One of the best ways to grow your wealth is to invest in growth stocks and hold them over the long term. By doing so, you can enjoy steady capital appreciation as you witness the rise in the value of your investment portfolio.
3 Business Information Stocks to Watch Amid Industry Woes
Increased demand for risk mitigation, cost reduction and productivity improvement solutions will likely help the Zacks Business - Information Services industry prosper. SPGI, VRSK and FDS are well-poised to benefit from this surge.
Here's Why You Should Retain FactSet Stock in Your Portfolio Now
FactSet thrives on robust, tech-savvy moves. Its commitment to sustainability is encouraging.
FactSet Earnings & Revenues Beat Estimates in Q1, Increase Y/Y
FDS's first-quarter fiscal 2025 organic revenues rise y/y across all the regions.
FactSet: A Strong Buy Into 2025
FactSet's high client retention rate and diverse revenue streams make it a strong buy, despite its high valuation. Recent product expansions, including GenAI solutions and IRN 2.0, enhance FactSet's market position and growth trajectory. FactSet's brand and distribution are key competitive advantages, supporting its premium valuation and long-term capital compounding.
